Target intelligence / Profile preview

Abhydrolase domain-containing protein 14A (ABHD14A)

Target
ABHD14A
Molecular classification
Enzyme, Serine hydrolase superfamily, Alpha/beta hydrolase fold protein
01

Overview

Abhydrolase domain-containing protein 14A (ABHD14A) is a human protein comprising 271 amino acids that features a conserved alpha/beta hydrolase fold, characteristic of the serine hydrolase superfamily. It is a predicted enzyme with hydrolase activity and is thought to localize to the membrane and cytoplasm. While ABHD14A is implicated, by sequence similarity and domain structure, in metabolic processes and possibly granule neuron development, its precise biochemical function in humans has not yet been experimentally validated. Some reports associate it genetically with rare diseases such as Chanarin-Dorfman syndrome and Williams-Beuren syndrome, but direct mechanistic links are lacking. Given its sequence similarity to ABHD14B—which functions as a lysine deacetylase—some databases conflate the two, highlighting a need for more specific annotation and study. ABHD14A is broadly expressed in many tissues but is not currently an established therapeutic target, nor is it linked to any approved drugs, mechanisms of drug action, biomarkers, or specific clinical safety concerns.

Other names
Protein ABHD14AABHD14AUNQ1913/PRO4373DKFZP564O243DORZ1Alpha/beta hydrolase domain-containing protein 14Aabhydrolase domain-containing protein 14A
02

Mechanism of action

No mechanisms of action are known for drugs against this molecule, due to absence of pharmacological agents or chemical probes targeting ABHD14A.

03

Biological functions

Predicted hydrolase activityPossible role in granule neuron developmentMay be involved in metabolic processes (typical of serine hydrolases)
04

Disease associations

Chanarin-Dorfman syndromeWilliams-Beuren syndrome(No direct strong evidence for other major disease roles; functional annotation is limited)

Beyond the preview

Go deeper on Abhydrolase domain-containing protein 14A (ABHD14A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abhydrolase domain-containing protein 14A (ABHD14A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call